Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia von Byrd, John C, Brown, Jennifer R, O'Brien, Susan, Barrientos, Jacqueline C, Kay, Neil E, Reddy, Nishitha M, Coutre, Steven, Tam, Constantine S, Mulligan, Stephen P, Jaeger, Ulrich, Devereux, Steve, Barr, Paul M, Furman, Richard R, Kipps, Thomas J, Cymbalista, Florence, Pocock, Christopher, Thornton, Patrick, Caligaris-Cappio, Federico, Robak, Tadeusz, Delgado, Julio, Schuster, Stephen J, Montillo, Marco, Schuh, Anna, de Vos, Sven, Gill, Devinder, Bloor, Adrian, Dearden, Claire, Moreno, Carol, Jones, Jeffrey J, Chu, Alvina D, Fardis, Maria, McGreivy, Jesse, Clow, Fong, James, Danelle F, Hillmen, Peter

Volltext

Double nuchal umbilical cord and breech presentation: The value of close follow-up von AL-KOUATLY, Huda B, SCHUSTER, Stephen S, SKUPSKI, Daniel W

Volltext

Double Nuchal Umbilical Cord and Breech Presentation von Al-Kouatly, Huda B., Schuster, Stephen S., Skupski, Daniel W.

Volltext

Data for: Bexarotene in Patients with Peripheral T-cell Lymphomas: Results of a Retrospective Study von Svoboda, Jakub

Volltext bestellen

Data for: Bexarotene in Patients with Peripheral T-cell Lymphomas: Results of a Retrospective Study von Svoboda, Jakub

Volltext bestellen

Can we brainstorm a solution to the shortage? von Schuster, Stephen S

Volltext

Would you rather be a physician or a technician? von Schuster, Stephen S

Volltext

Five-Year Outcomes for Refractory B-Cell Lymphomas with CAR T-Cell Therapy von Chong, Elise A, Ruella, Marco, Schuster, Stephen J

Volltext

Gold Catalysis: Isolation of Vinylgold Complexes Derived from Alkynes von Hashmi, A. Stephen K, Schuster, Andreas M, Rominger, Frank

Volltext

Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study von Schuster, Stephen J, Tam, Constantine S, Borchmann, Peter, Worel, Nina, McGuirk, Joseph P, Holte, Harald, Waller, Edmund K, Jaglowski, Samantha, Bishop, Michael R, Damon, Lloyd E, Foley, Stephen Ronan, Westin, Jason R, Fleury, Isabelle, Ho, P Joy, Mielke, Stephan, Teshima, Takanori, Janakiram, Murali, Hsu, Jing-Mei, Izutsu, Koji, Kersten, Marie José, Ghosh, Monalisa, Wagner-Johnston, Nina, Kato, Koji, Corradini, Paolo, Martinez-Prieto, Marcela, Han, Xia, Tiwari, Ranjan, Salles, Gilles, Maziarz, Richard T

Volltext

Bispecific antibodies for the treatment of lymphomas: Promises and challenges von Schuster, Stephen J.

Volltext

Tisagenlecleucel in Diffuse Large B-Cell Lymphoma. Reply von Schuster, Stephen J

Volltext

Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma von Schuster, Stephen J, Bishop, Michael R, Tam, Constantine S, Waller, Edmund K, Borchmann, Peter, McGuirk, Joseph P, Jäger, Ulrich, Jaglowski, Samantha, Andreadis, Charalambos, Westin, Jason R, Fleury, Isabelle, Bachanova, Veronika, Foley, S. Ronan, Ho, P. Joy, Mielke, Stephan, Magenau, John M, Holte, Harald, Pantano, Serafino, Pacaud, Lida B, Awasthi, Rakesh, Chu, Jufen, Anak, Özlem, Salles, Gilles, Maziarz, Richard T

Volltext

CD19-directed CAR T cells gain traction von Schuster, Stephen J

Volltext

Toxicities and outcomes of 616 ibrutinib-treated patients in the United States: a real-world analysis von Mato, Anthony R, Nabhan, Chadhi, Thompson, Meghan C, Lamanna, Nicole, Brander, Danielle M, Hill, Brian, Howlett, Christina, Skarbnik, Alan, Cheson, Bruce D, Zent, Clive, Pu, Jeffrey, Kiselev, Pavel, Goy, Andre, Claxton, David, Isaac, Krista, Kennard, Kaitlin H, Timlin, Colleen, Landsburg, Daniel, Winter, Allison, Nasta, Sunita D, Bachow, Spencer H, Schuster, Stephen J, Dorsey, Colleen, Svoboda, Jakub, Barr, Paul, Ujjani, Chaitra S

Volltext

NextGen CARs: the race is on von Schuster, Stephen J.

Volltext

Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study von Lesokhin, Alexander M, Ansell, Stephen M, Armand, Philippe, Scott, Emma C, Halwani, Ahmad, Gutierrez, Martin, Millenson, Michael M, Cohen, Adam D, Schuster, Stephen J, Lebovic, Daniel, Dhodapkar, Madhav, Avigan, David, Chapuy, Bjoern, Ligon, Azra H, Freeman, Gordon J, Rodig, Scott J, Cattry, Deepika, Zhu, Lili, Grosso, Joseph F, Bradley Garelik, M Brigid, Shipp, Margaret A, Borrello, Ivan, Timmerman, John

Volltext

PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma von Ansell, Stephen M, Lesokhin, Alexander M, Borrello, Ivan, Halwani, Ahmad, Scott, Emma C, Gutierrez, Martin, Schuster, Stephen J, Millenson, Michael M, Cattry, Deepika, Freeman, Gordon J, Rodig, Scott J, Chapuy, Bjoern, Ligon, Azra H, Zhu, Lili, Grosso, Joseph F, Kim, Su Young, Timmerman, John M, Shipp, Margaret A, Armand, Philippe

Volltext

Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas von Schuster, Stephen J, Svoboda, Jakub, Chong, Elise A, Nasta, Sunita D, Mato, Anthony R, Anak, Özlem, Brogdon, Jennifer L, Pruteanu-Malinici, Iulian, Bhoj, Vijay, Landsburg, Daniel, Wasik, Mariusz, Levine, Bruce L, Lacey, Simon F, Melenhorst, Jan J, Porter, David L, June, Carl H

Volltext

Efficacy and safety of CD19‐directed CAR‐T cell therapies in patients with relapsed/refractory aggressive B‐cell lymphomas: Observations from the JULIET, ZUMA‐1, and TRANSCEND tria... von Westin, Jason R., Kersten, Marie José, Salles, Gilles, Abramson, Jeremy S., Schuster, Stephen J., Locke, Frederick L., Andreadis, Charalambos

Volltext